{"acquisitions":[],"changes":[{"companyHref":"/c/trianabio-com","date":"2026-10-03","documentUrl":"https://atlasventure.com/portfolio/","domain":"trianabio.com","fact":"provenance:existence","name":"Triana Biomedicines","new":{"publisher":"Atlas Venture","status":"sourced","url":"https://atlasventure.com/portfolio/"},"old":{"publisher":"trianabio.com","status":"self-reported","url":"https://trianabio.com"},"publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-10-03","slug":"trianabio-com","status":"sourced","url":"https://whoraisedwhat.com/c/trianabio-com"},{"companyHref":"/c/trianabio-com","date":"2026-10-02","documentUrl":"https://atlasventure.com/portfolio/","domain":"trianabio.com","fact":"provenance:investor:atlas-venture","name":"Triana Biomedicines","new":{"publisher":"Atlas Venture","status":"sourced","url":"https://atlasventure.com/portfolio/"},"old":{"publisher":null,"status":"unknown","url":null},"publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-10-02","slug":"trianabio-com","status":"sourced","url":"https://whoraisedwhat.com/c/trianabio-com"}],"country":"US","description":"Triana Biomedicines develops molecular glue degraders, small molecules that force a disease-causing protein together with the cell's degradation machinery. It targets cancer patients whose disease is driven by proteins long considered undruggable. Its protein-pairing engine identifies matching E3 ligases, engineering glues rationally not by chance.","domain":"trianabio.com","employees":null,"founded":2019,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":["atlas-venture"],"lat":38.046407,"lng":-84.497039,"location":"Lexington, United States","multiples":[],"name":"Triana Biomedicines","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":120000000,"connectionsAmong":[],"currency":"USD","date":"2025-12-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"trianabio-com-2025-12-01-series-b","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-04-29","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"trianabio-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-04-29","status":"attributed","url":null},{"fact":"existence","publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},{"fact":"description","publisher":"trianabio.com","retrievedAt":"2026-10-03","status":"self-reported","url":"https://trianabio.com"},{"fact":"investor:atlas-venture","publisher":"Atlas Venture","retrievedAt":"2026-10-02","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[{"id":"investor:{\"actorKind\": \"investor\", \"name\": \"Atlas Venture\", \"role\": \"portfolio\", \"slug\": \"atlas-venture\", \"sources\": [{\"publisher\": \"Atlas Venture\", \"retrievedAt\": \"2026-10-02\", \"status\": \"sourced\", \"url\": \"https://atlasventure.com/portfolio/\"}]}","kind":"investor","sources":[{"publisher":"Atlas Venture","retrievedAt":"2026-10-02","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"text":"Triana Biomedicines was listed in Atlas Venture's portfolio, recorded 2026-10-02."}],"generatedAt":"2026-11-09","investors":[{"actorKind":"investor","name":"Atlas Venture","role":"portfolio","slug":"atlas-venture","sources":[{"publisher":"Atlas Venture","retrievedAt":"2026-10-02","status":"sourced","url":"https://atlasventure.com/portfolio/"}]}],"state":"insufficient-evidence","tldr":[]},"techStack":["Typekit","Adobe Fonts","Afterpay","Sentry","Squarespace","Squarespace Commerce","Stimulus","web-vitals","moment 0","@sentry/browser"],"totalRaisedUsd":230000000,"traction":[],"updatedAt":"2026-10-03","valuations":[]}